VIA
Virtus Investment Advisers Portfolio holdings
AUM
$296M
1-Year Return
31.42%
This Quarter Return
-0.81%
1 Year Return
+31.42%
3 Year Return
+126.24%
5 Year Return
–
10 Year Return
–
AUM
$147M
AUM Growth
-$239K
(-0.16%)
Cap. Flow
+$3.24M
Cap. Flow
% of AUM
2.2%
Top 10 Holdings %
Top 10 Hldgs %
31.07%
Holding
300
New
41
Increased
19
Reduced
68
Closed
58
Top Buys
| 1 |
PIMCO Enhanced Short Maturity Active ESG ETF
EMNT
|
$10.8M |
| 2 |
Virtus Duff & Phelps Clean Energy ETF
VCLN
|
$4.17M |
| 3 |
Janus Henderson AAA CLO ETF
JAAA
|
$1.34M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
$1.25M |
| 5 |
NVIDIA
NVDA
|
$1.04M |
Top Sells
| 1 |
iQIYI
IQ
|
$2.35M |
| 2 |
iShares ESG Aware MSCI USA ETF
ESGU
|
$1.57M |
| 3 |
Starbucks
SBUX
|
$996K |
| 4 |
Plains GP Holdings
PAGP
|
$943K |
| 5 |
Ryerson Holding
RYI
|
$910K |
Sector Composition
| 1 | Technology | 14.78% |
| 2 | Consumer Discretionary | 12.16% |
| 3 | Healthcare | 11.4% |
| 4 | Industrials | 10.21% |
| 5 | Financials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
KB Home
KBH
$4.49B
| $290K | 0.2% |
+6,276
| New | +$290K |
|
127
Phibro Animal Health
PAHC
$1.58B
| $290K | 0.2% |
22,744
+6,200
| +37% | +$79.2K |
|
128
Merck
MRK
$210B
| $290K | 0.2% |
2,821
-4,444
| -61% | -$458K |
|
129
HEICO
HEI
$44.9B
| $290K | 0.2% |
1,788
| – | – |
|
130
Veracyte
VCYT
$2.48B
| $287K | 0.2% |
12,864
| – | – |
|
131
Exelixis
EXEL
$10.1B
| $284K | 0.19% |
+13,000
| New | +$284K |
|
132
Amphastar Pharmaceuticals
AMPH
$1.36B
| $281K | 0.19% |
6,109
| – | – |
|
133
Carrier Global
CARR
$54.1B
| $279K | 0.19% |
5,052
| – | – |
|
134
DaVita
DVA
$9.69B
| $279K | 0.19% |
2,949
-344
| -10% | -$32.5K |
|
|
AGS
135
DELISTED
PlayAGS
AGS
| $278K | 0.19% |
42,567
+17,000
| +66% | +$111K |
|
136
Ingersoll Rand
IR
$31.5B
| $271K | 0.18% |
4,251
| – | – |
|
137
Neurocrine Biosciences
NBIX
$13.9B
| $268K | 0.18% |
+2,381
| New | +$268K |
|
138
Commault Systems
CVLT
$7.88B
| $263K | 0.18% |
3,886
| – | – |
|
139
Molina Healthcare
MOH
$9.26B
| $262K | 0.18% |
800
-93
| -10% | -$30.5K |
|
140
Encompass Health
EHC
$12.5B
| $262K | 0.18% |
3,901
| – | – |
|
141
ADMA Biologics
ADMA
$4.04B
| $261K | 0.18% |
72,895
+12,462
| +21% | +$44.6K |
|
142
Blackbaud
BLKB
$3.22B
| $260K | 0.18% |
+3,703
| New | +$260K |
|
143
Super Micro Computer
SMCI
$24.2B
| $259K | 0.18% |
+9,460
| New | +$259K |
|
144
Saic
SAIC
$4.98B
| $256K | 0.17% |
2,430
| – | – |
|
145
Federated Hermes
FHI
$4.15B
| $256K | 0.17% |
7,549
| – | – |
|
146
Cytokinetics
CYTK
$5.95B
| $255K | 0.17% |
8,664
+720
| +9% | +$21.2K |
|
147
Weis Markets
WMK
$1.79B
| $253K | 0.17% |
4,022
| – | – |
|
148
Amneal Pharmaceuticals
AMRX
$3B
| $252K | 0.17% |
59,710
+15,230
| +34% | +$64.3K |
|
149
Oracle
ORCL
$626B
| $252K | 0.17% |
2,376
-277
| -10% | -$29.3K |
|
|
NEWR
150
DELISTED
New Relic, Inc.
NEWR
| $245K | 0.17% |
2,866
| – | – |
|